13F filing recap · Q3 2021
What did Viking Global Investors buy in Q3 2021?
Reported stock-position changes between this filing and the previous one.
Stock value
$36.35B
Positions
95
Estimated turnover
71.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
DNAGinkgo Bioworks Holdings, Inc.$3.93Breported value+339.06M sharesGEGeneral Electric Company$1.74Breported value+16.92M sharesMCDMcdonald’s Corporation$720.99Mreported value+2.99M sharesCMCSAComcast Corporation$569.18Mreported value+10.18M sharesFTCHFarfetch Limited$432.45Mreported value+11.54M sharesPINSPinterest, Inc.$368.41Mreported value+7.23M sharesZMZoom Communications, Inc.$308.31Mreported value+1.18M sharesTSLATesla, Inc.$297.63Mreported value+383.8K sharesUBERUber Technologies, Inc.$286.36Mreported value+6.39M sharesWTWWillis Towers Watson Plc$269.62Mreported value+1.16M sharesCPCanadian Pacific Kansas City Ltd/cn$224.34Mreported value+3.45M sharesPRCTProcept Biorobotics Corporation$187.24Mreported value+4.91M sharesHDBHdfc Bank Limited$122.73Mreported value+1.68M sharesOLPXOlaplex Holdings, Inc.$74.05Mreported value+3.02M sharesRLYBRallybio Corporation$73.74Mreported value+4.19M sharesILMNIllumina, Inc.$63.00Mreported value+155.3K sharesVTEXVtex$62.55Mreported value+3.04M sharesATVIActivision Blizzard, Inc.$61.62Mreported value+796.2K sharesMETMetlife, Inc.$59.21Mreported value+959.1K sharesAVIRAtea Pharmaceuticals, Inc.$58.03Mreported value+1.66M sharesICVXIcosavax Inc$54.82Mreported value+1.85M sharesCLDXCelldex Therapeutics, Inc.$41.16Mreported value+762.3K sharesNUVLNuvalent, Inc.$37.16Mreported value+1.65M sharesSMFRGenedx Holdings Corp$22.77Mreported value+3.00M sharesMEKAMeli Kaszek Pioneer Corp$11.05Mreported value+1.00M sharesONONOn Holding AG$9.04Mreported value+300.0K shares